2006
DOI: 10.1016/j.jpeds.2005.08.045
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Buserelin Stimulation Test in Diagnosing Gonadotropin Deficiency in Males with Delayed Puberty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
19
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(23 citation statements)
references
References 36 publications
3
19
0
1
Order By: Relevance
“…This is important because cut‐off values in general are only valid for the age and maturation stage of the boys tested and for the assays used. A previous study, using buserelin as the GnRHa and a similar immunoassay, had very comparable settings with respect to age and pubertal stage and reported a very similar cut‐off for the LH (4 h) value of 5·0 IU/l . With respect to inhibin B, we confirmed the diagnostic strength of this parameter for distinguishing HH from CDGP in prepubertal boys, as reported by Coutant et al .…”
Section: Discussionsupporting
confidence: 87%
“…This is important because cut‐off values in general are only valid for the age and maturation stage of the boys tested and for the assays used. A previous study, using buserelin as the GnRHa and a similar immunoassay, had very comparable settings with respect to age and pubertal stage and reported a very similar cut‐off for the LH (4 h) value of 5·0 IU/l . With respect to inhibin B, we confirmed the diagnostic strength of this parameter for distinguishing HH from CDGP in prepubertal boys, as reported by Coutant et al .…”
Section: Discussionsupporting
confidence: 87%
“…Our data across the pubertal transition are consistent with published data on the distinction of constitutional delay of puberty from gonadotropin deficiency (35,36). The 90% population limits we demonstrate in young prepubertal children may also provide guidance in the management of early puberty in boys (37).…”
Section: Discussionsupporting
confidence: 90%
“…GnD males responded to GnRHag administration at 5-day intervals with significant potentiation of LH release, but the LH response was subnormal and transient, testosterone did not increase, and the FSH-predominance of severe GnD (9, 19) persisted. One-year’s treatment of a patient with partial GnD, altering the interval of GnRHag administration and varying the dosage by ten-fold, did not lead to sufficiently sustained repetitive LH and FSH responses to normalize testosterone levels or to correct azospermia.…”
Section: Discussionmentioning
confidence: 94%